Emily Littlejohn

585 total citations
14 papers, 357 citations indexed

About

Emily Littlejohn is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Emily Littlejohn has authored 14 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Emily Littlejohn's work include Systemic Lupus Erythematosus Research (11 papers), Systemic Sclerosis and Related Diseases (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Emily Littlejohn is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Systemic Sclerosis and Related Diseases (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Emily Littlejohn collaborates with scholars based in United States. Emily Littlejohn's co-authors include Seetha U. Monrad, Emily C. Somers, Wendy Marder, Emily Lewis, Sheila Francis, W. Joseph McCune, Frances J.D. Smith, Trine N. Jørgensen, Nicholas Chan and M. Elaine Husni and has published in prestigious journals such as Circulation, Frontiers in Immunology and Best Practice & Research Clinical Rheumatology.

In The Last Decade

Emily Littlejohn

12 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Littlejohn United States 7 202 102 73 60 43 14 357
Viktoriya Pavlych Italy 6 161 0.8× 65 0.6× 62 0.8× 64 1.1× 11 0.3× 11 313
Liqi Bi China 16 259 1.3× 184 1.8× 108 1.5× 51 0.8× 19 0.4× 29 468
Dong-Hui Zheng China 14 276 1.4× 81 0.8× 124 1.7× 56 0.9× 14 0.3× 28 554
Faith Li‐Ann Chia Singapore 9 196 1.0× 85 0.8× 32 0.4× 40 0.7× 13 0.3× 18 296
Bojana Stamenković Serbia 11 166 0.8× 110 1.1× 64 0.9× 37 0.6× 14 0.3× 41 449
M. Nielen Netherlands 7 475 2.4× 95 0.9× 54 0.7× 98 1.6× 19 0.4× 14 599
Penny Shaw United States 8 285 1.4× 252 2.5× 49 0.7× 41 0.7× 13 0.3× 8 420
J. Pinto-Tasende Spain 10 273 1.4× 188 1.8× 84 1.2× 136 2.3× 9 0.2× 42 398
Amy Wasserman United States 8 177 0.9× 78 0.8× 43 0.6× 51 0.8× 4 0.1× 15 327
Kasper Fjellhaugen Hjuler Denmark 14 175 0.9× 386 3.8× 55 0.8× 63 1.1× 11 0.3× 20 548

Countries citing papers authored by Emily Littlejohn

Since Specialization
Citations

This map shows the geographic impact of Emily Littlejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Littlejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Littlejohn more than expected).

Fields of papers citing papers by Emily Littlejohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Littlejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Littlejohn. The network helps show where Emily Littlejohn may publish in the future.

Co-authorship network of co-authors of Emily Littlejohn

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Littlejohn. A scholar is included among the top collaborators of Emily Littlejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Littlejohn. Emily Littlejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Layoun, Habib, et al.. (2025). Autoimmune Pericarditis: Diagnosis and New Therapeutics. Current Cardiology Reports. 27(1). 114–114. 1 indexed citations
2.
Littlejohn, Emily, et al.. (2024). Longitudinal antinuclear antibody titers in systemic lupus erythematosus and other rheumatic diseases. Frontiers in Medicine. 11. 1441221–1441221.
3.
4.
Smith, Frances J.D., et al.. (2022). Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus. Frontiers in Immunology. 13. 888501–888501. 6 indexed citations
5.
Wang, Tom Kai Ming, Nicholas Chan, Mohamed Khayata, et al.. (2022). Cardiovascular Manifestations, Imaging, and Outcomes in Systemic Lupus Erythematosus: An Eight-Year Single Center Experience in the United States. Angiology. 73(9). 877–886. 5 indexed citations
6.
Khayata, Mohamed, Tom Kai Ming Wang, Nicholas Chan, et al.. (2021). Multimodality Cardiac Imaging in Patients with Systemic Lupus Erythematosus. Current Problems in Cardiology. 48(3). 101048–101048. 2 indexed citations
7.
8.
Littlejohn, Emily. (2020). Hydroxychloroquine use in the COVID-19 patient. Cleveland Clinic Journal of Medicine. 8 indexed citations
9.
Littlejohn, Emily. (2020). Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic. Cleveland Clinic Journal of Medicine. 7 indexed citations
10.
Wang, Tom Kai Ming, Nicholas Chan, Mohamed Khayata, et al.. (2020). Abstract 13131: Cardiovascular Manifestations and Outcomes in Systemic Lupus Erythematosus: The Cleveland Clinic Contemporary Experience. Circulation. 142(Suppl_3).
11.
Littlejohn, Emily. (2019). Pregnancy and rheumatoid arthritis. Best Practice & Research Clinical Obstetrics & Gynaecology. 64. 52–58. 21 indexed citations
12.
Littlejohn, Emily & Seetha U. Monrad. (2018). Early Diagnosis and Treatment of Rheumatoid Arthritis. Primary Care Clinics in Office Practice. 45(2). 237–255. 212 indexed citations
13.
14.
Marder, Wendy, Emily Littlejohn, & Emily C. Somers. (2016). Pregnancy and autoimmune connective tissue diseases. Best Practice & Research Clinical Rheumatology. 30(1). 63–80. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viktoriya Pavlych Breakdown of academic impact, for papers by Liqi Bi Breakdown of academic impact, for papers by Dong-Hui Zheng Breakdown of academic impact, for papers by Faith Li‐Ann Chia Breakdown of academic impact, for papers by Bojana Stamenković Breakdown of academic impact, for papers by M. Nielen Breakdown of academic impact, for papers by Penny Shaw Breakdown of academic impact, for papers by J. Pinto-Tasende Breakdown of academic impact, for papers by Amy Wasserman Breakdown of academic impact, for papers by Kasper Fjellhaugen Hjuler
Rankless by CCL
2026